These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 9105566

  • 1. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
    Nestel P, Simons L, Barter P, Clifton P, Colquhoun D, Hamilton-Craig I, Sikaris K, Sullivan D.
    Atherosclerosis; 1997 Mar 21; 129(2):231-9. PubMed ID: 9105566
    [Abstract] [Full Text] [Related]

  • 2. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia.
    Bredie SJ, Westerveld HT, Knipscheer HC, de Bruin TW, Kastelein JJ, Stalenhoef AF.
    Neth J Med; 1996 Aug 21; 49(2):59-67. PubMed ID: 8824106
    [Abstract] [Full Text] [Related]

  • 3. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF.
    Am J Cardiol; 1995 Feb 15; 75(5):348-53. PubMed ID: 7856526
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.
    Sweany AE, Shapiro DR, Tate AC, Goldberg RB, Stein EA.
    Clin Ther; 1995 Feb 15; 17(2):186-203. PubMed ID: 7614520
    [Abstract] [Full Text] [Related]

  • 8. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.
    Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G.
    Metabolism; 1999 Jan 15; 48(1):47-54. PubMed ID: 9920144
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
    Vázquez M, Zambón D, Hernández Y, Adzet T, Merlos M, Ros E, Laguna JC.
    Br J Clin Pharmacol; 1998 Mar 15; 45(3):265-9. PubMed ID: 9517370
    [Abstract] [Full Text] [Related]

  • 15. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 16. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia.
    Bell DS.
    Clin Ther; 1995 Jul 01; 17(5):901-10. PubMed ID: 8595642
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of simvastatin in the treatment of hyperlipidemia].
    Lu ZL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug 01; 21(4):216-8, 253. PubMed ID: 8194433
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.
    Tikkanen MJ, Laakso M, Ilmonen M, Helve E, Kaarsalo E, Kilkki E, Saltevo J.
    Diabetes Care; 1998 Apr 01; 21(4):477-81. PubMed ID: 9571327
    [Abstract] [Full Text] [Related]

  • 19. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Apr 01; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 20. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
    Kontopoulos AG, Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Mayroudi MC, Boudoulas H.
    Coron Artery Dis; 1996 Nov 01; 7(11):843-50. PubMed ID: 8993943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.